NCT01003847已完成4 期
Differential Metabolic Effects of Fenofibrate and Fatty Acid
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 150
- 试验地点
- 1
- 主要终点
- flow-mediated dilation
研究概览
简要总结
The investigators hypothesize that fenofibrate and fatty acid may have different metabolic effects in hypertriglyceridemic patients
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 25 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •hypertriglyceridemia
排除标准
- •Overt liver disease Chronic renal failure Hypothyroidism Myopathy Uncontrolled diabetes Severe hypertension
研究组 & 干预措施
fenofibrate
Active Comparator
干预措施: fenofibrate, fatty acid, placebo (Drug)
fatty acid
Active Comparator
drug
干预措施: fenofibrate, fatty acid, placebo (Drug)
Placebo
Active Comparator
干预措施: fenofibrate, fatty acid, placebo (Drug)
结局指标
主要结局
flow-mediated dilation
时间窗: 8 weeks of treatment
次要结局
- insulin resistance(8 weeks of treatment)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Effects of fenofibrate or eiocosapentaenoic acid(EPA) on glucose metabolism, fat distribution, adipocytokines and inflammatory cytokines in type 2 Diabetes.type 2 DiabetesJPRN-UMIN000000969Kobe University Hospital50
已完成
4 期
Vascular and Metabolic Effects of Fenofibrate/Omega vs FenofibrateHypertriglyceridemiaNCT01666041Gachon University Gil Medical Center120
终止
不适用
Effect of Different Fatty Acids on Metabolic Rate in Overweight WomeOverweight/obesityDiet and Nutrition - ObesityACTRN12615000670572Ass. Prof Alison Coates40
终止
2 期
Fenofibrate and Propranolol in Burn PatientsBurnNCT02452255The University of Texas Medical Branch, Galveston18
终止
不适用
Effects of Fenofibrate on Metabolic and Reproductive Parameters in Polycystic Ovary SyndromePolycystic Ovary SyndromeNCT00884819Lawson Health Research Institute4